StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3086% above fair value
$114.63−1.25 (-1.07%)

Close on Nov 20, 2026Market cap $23.36BP/E 61.0Yield –

Incyte shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Incyte's shares outstanding was 203M at Sep 30, 2026. For fiscal 2025 it was 201M, down 4.7% from the year before. Over ten years it grew 0.7% a year on average. The highest annual figure on record is 226M in fiscal 2023.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025201M-4.7%
FY2024Dec 31, 2024211M-6.8%
FY2023Dec 31, 2023226M+0.9%
FY2022Dec 31, 2022224M+0.8%
FY2021Dec 31, 2021222M+1.8%
FY2020Dec 31, 2020218M+0.2%
FY2019Dec 31, 2019218M+0.9%
FY2018Dec 31, 2018216M+5.4%
FY2017Dec 31, 2017205M+5.4%
FY2016Dec 31, 2016194M+3.6%
FY2015Dec 31, 2015187M+11.5%
FY2014Dec 31, 2014168M+13.2%
FY2013Dec 31, 2013148M+14.4%
FY2012Dec 31, 2012130M+3.5%
FY2011Dec 31, 2011125M+3.1%
FY2010Dec 31, 2010122M+18.2%
FY2009Dec 31, 2009103M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026203M+0.9%
Q2 FY2026Jun 30, 2026208M+4.8%
Q1 FY2026Mar 31, 2026207M+4.4%
Q4 FY2025Dec 31, 2025205M-1.1%
Q3 FY2025Sep 30, 2025201M+2.9%
Q2 FY2025Jun 30, 2025199M-8.9%
Q1 FY2025Mar 31, 2025198M-12.8%
Q4 FY2024Dec 31, 2024207M-8.7%
Q3 FY2024Sep 30, 2024196M-13.4%
Q2 FY2024Jun 30, 2024218M-3.3%
Q1 FY2024Mar 31, 2024227M+0.7%
Q4 FY2023Dec 31, 2023226M+0.7%
Q3 FY2023Sep 30, 2023226M+0.9%
Q2 FY2023Jun 30, 2023226M+0.9%
Q1 FY2023Mar 31, 2023226M+1.2%
Q4 FY2022Dec 31, 2022225M+1.4%
Q3 FY2022Sep 30, 2022224M+0.9%
Q2 FY2022Jun 30, 2022224M+0.6%
Q1 FY2022Mar 31, 2022223M+0.5%
Q4 FY2021Dec 31, 2021222M+0.3%
Q3 FY2021Sep 30, 2021222M+1.6%
Q2 FY2021Jun 30, 2021222M+0.8%
Q1 FY2021Mar 31, 2021222M+2.4%
Q4 FY2020Dec 31, 2020221M+1.2%
Q3 FY2020Sep 30, 2020219M+0.5%
Q2 FY2020Jun 30, 2020220M+1.4%
Q1 FY2020Mar 31, 2020217M-0.2%
Q4 FY2019Dec 31, 2019219M+1.2%
Q3 FY2019Sep 30, 2019218M+0.8%
Q2 FY2019Jun 30, 2019217M+1.1%
Q1 FY2019Mar 31, 2019217M+2.5%
Q4 FY2018Dec 31, 2018216M+2.3%
Q3 FY2018Sep 30, 2018216M+1.6%
Q2 FY2018Jun 30, 2018215M+4.9%
Q1 FY2018Mar 31, 2018212M+8.4%
Q4 FY2017Dec 31, 2017211M+8.2%
Q3 FY2017Sep 30, 2017213M–
Q2 FY2017Jun 30, 2017205M–
Q1 FY2017Mar 31, 2017195M–
Q4 FY2016Dec 31, 2016195M–

More Incyte figures

See a number that looks wrong?